某院慢性病患者超说明书用药调查分析
Investigation and Analysis of Off-Label Drug Use in Patients with Chronic Diseases in a Hospital
摘要: 目的:调查我院慢性病患者的超说明书用药情况,分析研究并制定相应的管理对策,为规范超说明书用药,促进合理用药提供依据。方法:筛选HIS系统中2017年12月我院社区门诊慢性病处方2020张,依据药品说明书的规定,从适应症、用药频次、用药剂量和给药途径四个方面进行处方点评,并对点评结果进行统计分析,制定相应的管理对策。结果:慢性病患者中超说明书用药的处方数为688张,超说明书使用率为34.01%。超说明书用药涉及的次数为1030次,其中超适应症531次,占51.55%;超用药频次260次,占25.24%;超用量237次,占23.01%;超给药途径2次。结论:我院社区门诊慢性病患者中超说明书用药情况普遍,存在使用风险,需要制定相应的管理对策,降低用药风险,促进合理用药。
Abstract: Objective: To investigate the situation of Off-label Drug Use in the patients with chronic diseases in our hospital, analyze and study and make corresponding management countermeasure, provide the basis for normalizing the overstatement drug use and promoting the rational drug use. Methods: Screening of 2020 prescriptions for chronic diseases in community outpatient clinics in the HIS system in December 2017. According to the provisions of the drug manual, prescription reviews are made from four aspects: indications, frequency, dosage and route of administration, and the results are statistically analyzed, and corresponding management countermeasures are formulated. Results: The number of prescriptions for out of Off-label Drug Use in chronic diseases was 688, and the rate of Off-label Drug Use was 34.01%. The number of Off-label Drug Use was 1030 times, of which 531 times were over-indication, accounting for 51.55%; Hypermedication frequency 260 times, ac-counting for 25.24%; Excess dosage 237 times, accounting for 23.01%; Hyperdrug route 2 times. Conclusions: For the patients with chronic diseases in the community outpatient clinic of our hospital, Off-label Drug use is common and there is a risk of use. Therefore, corresponding management measures should be formulated to reduce the risk of medication and promote rational drug use.
文章引用:庞允. 某院慢性病患者超说明书用药调查分析[J]. 药物资讯, 2018, 7(5): 97-101. https://doi.org/10.12677/PI.2018.75018

参考文献

[1] 贾美楠. 医院超说明书用药原因分析及管理对策[J]. 中国卫生产业, 2017, 14(21): 144-145.
[2] Radley, D.C., Finkel-stein, S.N. and Stafford, R.S. (2006) Off-Label Prescribing among Office-Based Physicians. Archives of Internal Medicine, 166, 1021-1026. [Google Scholar] [CrossRef] [PubMed]
[3] 李军珂. 儿科门诊处方超说明书用药情况调查[J]. 淮海医药, 2017, 35(4): 471- 473.
[4] 罗伟华, 李加林. 门、急诊超说明书用药处方分析与对策研究[J].药学实践杂志, 2015, 33(2): 183-186.
[5] 李玉堂, 杨昌云, 王佳坤, 等. 超说明书用药原因分析及对策[J]. 医药导报, 2012, 31(3): 400-402.
[6] Legro, R.S. (2015) Introduction: On-Label and Off-Label Drug Use in Reproductive Medicine. Fertility and Sterility, 103, 581-582. [Google Scholar] [CrossRef] [PubMed]
[7] 胡偌碧, 徐春敏, 赵志刚. 超药品说明书用药及其国际经验与思考[J]. 药品评价, 2012, 9(2): 6-10.
[8] Tabarrok, A. (2009) From Off-Label Prescribing towards a New FDA. Medical Hypotheses, 72, 11-13. [Google Scholar] [CrossRef] [PubMed]
[9] 丁爱丽, 李野, 郝东卫, 等. 某医院2012年超说明书用药管理初探[J]. 现代医院管理, 2014, 12(1): 54-55.
[10] 刘宇. 药品说明书之外用法的法律风险提示及对策建议[J]. 协和医学杂志, 2010, 1(1): 117-118.
[11] 广东省药学会. 关于印发《药品未注册用法专家共识》的通知[J]. 今日药学, 2010, 20(4): 1-3.
[12] 路俊华. 1066份药品说明书执行标准项的调查分析[J]. 中国合理用药探索, 2017, 14(1): 38- 41.
[13] 刘利军, 肖龙华, 李睿, 等. 超说明书用药认识问题及管理对策研究[J]. 中国医院用药评价与分析, 2014, 14(4): 361-364.
[14] 蔡建, 韩辉, 王莉. 社区卫生服务中心儿科门诊超说明书用药调查[J]. 上海医药, 2015(2): 24-26.
[15] 李亚昙, 阿衣古丽•玉努斯, 滕亮, 等. 新疆某三甲医院儿科门诊及住院超药品说明书用药情况对比分析[J]. 中国医院药学杂志, 2017, 37(2): 164-168.
[16] 韩娟. 关于超说明书用药药事管理初探[J]. 中国药事, 2012, 26(1): 8-10.